XACT Robotics has successfully completed a $36 million financing round, which will fund the continued development of its XACT Robotic System, the company stated.
The hands-free device, which received U.S. Food and Drug Administration clearance in October, allows users to plan and navigate procedures using imaging. XACT Robotics will highlight the technology at RSNA 2019.
Investors in this latest round of financing included Chasing Value Asset Management, Mazor Robotics (acquired by Medtronic in 2018), and Corindus Vascular Robotics (acquired by Siemens Healthineers this year).
